|
Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer: Survival results from STAMPEDE (NCT00268476). |
|
|
Honoraria - Astellas Pharma; Bayer; Janssen; Oncogenex; Pierre Fabre; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Merck; Sanofi |
Speakers' Bureau - Astellas Pharma; Ferring; Pierre Fabre; Sanofi |
Research Funding - Astellas Pharma (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst) |
|
|
|
Research Funding - Astellas Pharma; Janssen-Cilag; Novartis; Pfizer; Sanofi |
Travel, Accommodations, Expenses - Lilly |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Dendreon; Sanofi |
Speakers' Bureau - Sanofi |
Research Funding - Ferring |
|
|
|
Consulting or Advisory Role - FirstWord; ISSECAM supported by Astra Zeneca, Janssen, Astellas and Ipsen; Janssen Research & Development; Sandoz; Takeda |
Patents, Royalties, Other Intellectual Property - Employer Rewards to Investor |
Expert Testimony - Vitality Life |
Travel, Accommodations, Expenses - Takeda |
Other Relationship - Astellas Pharma |
|
|
No Relationships to Disclose |
|
|
Research Funding - Astellas Pharma; Janssen; Novartis; Pfizer; Sanofi |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bayer; BN ImmunoTherapeutics; Janssen |
Consulting or Advisory Role - Bayer Schering Pharma; BN ImmunoTherapeutics; Janssen |
Research Funding - Bayer Schering Pharma (Inst) |
Travel, Accommodations, Expenses - Bayer Schering Pharma; Janssen |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Astellas Pharma |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Sanofi |
Travel, Accommodations, Expenses - Sanofi |
|
|
Research Funding - Astellas Pharma; Janssen; Novartis; Pfizer; Sanofi |